Our results indicated the association of the XPD 312Asp/Asn heterozygous genotype with an increased risk of bladder cancer, whereas the OGG1 326Ser/Cys heterozygous genotype has exhibited the protective effect. Here, OGG1 is linked to urinary bladder cancer.